Bridges Investment Management Inc. Sells 1,603 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Bridges Investment Management Inc. lowered its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 173,663 shares of the medical equipment provider’s stock after selling 1,603 shares during the period. Intuitive Surgical makes up 1.3% of Bridges Investment Management Inc.’s portfolio, making the stock its 25th biggest position. Bridges Investment Management Inc.’s holdings in Intuitive Surgical were worth $90,645,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in ISRG. Bennett Selby Investments LP raised its holdings in Intuitive Surgical by 3.9% in the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock valued at $234,000 after acquiring an additional 17 shares in the last quarter. Onefund LLC raised its holdings in Intuitive Surgical by 1.9% in the 4th quarter. Onefund LLC now owns 947 shares of the medical equipment provider’s stock valued at $494,000 after acquiring an additional 18 shares in the last quarter. LVW Advisors LLC raised its holdings in Intuitive Surgical by 1.3% in the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock valued at $756,000 after acquiring an additional 19 shares in the last quarter. Wesbanco Bank Inc. raised its holdings in Intuitive Surgical by 1.6% in the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock valued at $635,000 after acquiring an additional 19 shares in the last quarter. Finally, Journey Strategic Wealth LLC raised its holdings in Intuitive Surgical by 1.9% in the 4th quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider’s stock valued at $542,000 after acquiring an additional 19 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Analysts Set New Price Targets

ISRG has been the subject of several analyst reports. Bernstein Bank lifted their price objective on Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a report on Monday, January 27th. Leerink Partners boosted their price target on Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. BTIG Research boosted their price target on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th. Evercore ISI boosted their price target on Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Finally, Piper Sandler reissued an “overweight” rating and set a $670.00 price target (up previously from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. One research analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have given a buy rating to the company. Based on data from MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Trading Up 1.7 %

NASDAQ ISRG opened at $573.15 on Friday. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The business’s 50-day moving average price is $569.87 and its two-hundred day moving average price is $529.06. The firm has a market capitalization of $204.14 billion, a PE ratio of 89.42, a price-to-earnings-growth ratio of 5.85 and a beta of 1.39.

Insider Activity at Intuitive Surgical

In related news, CFO Jamie Samath sold 270 shares of the company’s stock in a transaction dated Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total transaction of $145,840.50. Following the sale, the chief financial officer now owns 8,757 shares in the company, valued at $4,730,093.55. This represents a 2.99 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the sale, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 8,077 shares of company stock worth $4,620,025 in the last 90 days. Corporate insiders own 0.90% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.